Cytogenetics

Cytogenetics is the branch of genetics that studies chromosomes, particularly their number, structure, and behavior within cells. It connects the microscopic organization of hereditary material with patterns of inheritance and with changes in development and health. Chromosome analysis can reveal gains, losses, and rearrangements of genetic material that are not adequately described by examining individual genes alone. (genome.gov)

The field combines classical microscopy and chromosome staining with molecular methods. Karyotyping examines chromosome complements and banding patterns; fluorescence in situ hybridization locates selected DNA sequences within chromosomes or nuclei; and cytogenomic microarrays detect changes in DNA copy number across the genome. These approaches provide different, complementary views of chromosome variation. (genome.gov)

Cytogenetics has contributed to the experimental foundations of inheritance, the investigation of chromosome evolution, and the identification of constitutional chromosome conditions and acquired changes in cancer. Its scope extends from chromosome behavior in plants and animals to laboratory analysis in human medicine, with interpretation depending on the biological context and the capabilities of each method. (dosequis.colorado.edu)

Chromosomes as the Objects of Cytogenetic Study

Cytogenetics studies the number, structure, organization, and inheritance of chromosomes, connecting their physical appearance with their behavior in cells. Its characteristic scale is the chromosome or chromosome segment: it asks how hereditary material is packaged, where particular regions lie, and how chromosomes are transmitted during division. Gene-centered genetics instead emphasizes individual genes, their variants, and inheritance; cell biology examines cellular structures and processes more broadly; sequence-based genomics describes the genome through nucleotide sequences and their relationships. These perspectives overlap, but a chromosome image provides information about physical organization and individual cells that is different from a DNA sequence alone. Microscopy is foundational to cytogenetics, although chromosome-level analysis also includes molecular methods. (genome.gov)

A typical unreplicated nuclear chromosome in a eukaryote contains one long, double-stranded DNA molecule associated with proteins. This DNA–protein material is chromatin; DNA wrapped around histone proteins forms repeating nucleosomes, which contribute to its packaging. Following replication, a chromosome consists of two sister chromatids, each containing a DNA molecule, held together until segregation. The centromere corresponds to the primary constriction of a condensed chromosome and divides it into a short arm, designated p, and a long arm, designated q. Centromere position therefore contributes to chromosome shape rather than necessarily marking its geometric midpoint. Telomeres, composed of repetitive DNA and associated proteins at the ends of linear chromosomes, protect those ends. The familiar doubled chromosome shape represents a replicated, condensed chromosome, not its permanent appearance throughout the cell cycle. (genome.gov)

A chromosome complement is the complete chromosome collection in a cell. Haploid cells have one set, denoted $n$, whereas diploid cells have two sets, denoted $2n$. In a typical human diploid nuclear complement, $2n=46$: 22 pairs are autosomes, and the remaining two are sex chromosomes, commonly XX or XY. Human gametes normally contain $n=23$. Homologous chromosomes carry corresponding genes, although their alleles may differ; one homolog is ordinarily inherited from each parent. Homologs are thus distinct from sister chromatids, which arise by copying a single chromosome. The human X and Y are not homologous across their entire lengths. Neither 46 chromosomes nor the human sex-chromosome arrangement is a universal model: dogs, for example, typically have 39 chromosome pairs. Chromosome number must be interpreted in relation to species and cell type. (genome.gov)

During the S phase of the cell cycle, DNA replication doubles DNA content without immediately doubling chromosome number: a typical human cell subsequently has 46 replicated chromosomes comprising 92 chromatids. During mitosis, chromosomes condense in prophase, becoming distinguishable as individual bodies. After nuclear-envelope breakdown, kinetochores assembled at centromeres attach to microtubules of the mitotic spindle. At metaphase, replicated chromosomes align near the spindle equator; their compact form makes this stage particularly useful for counting chromosomes and examining morphology. At anaphase, sister chromatids separate and become daughter chromosomes, moving toward opposite poles. Chromosomes then decondense as daughter nuclei form. Conventional cytological preparations therefore capture particular stages rather than showing chromosomes in an unchanging configuration. (ncbi.nlm.nih.gov)

Meiosis follows one round of DNA replication with two successive divisions. During prophase I, homologous chromosomes pair, or synapse, with a synaptonemal complex assembling between them. Crossing over exchanges DNA between nonsister chromatids; its physical consequences become visible as chiasmata when homologs begin separating during diplotene. Each paired unit, termed a bivalent, contains two homologous chromosomes and four chromatids. Homologs segregate at the first division while sister chromatids remain joined; the second division separates the sisters without another intervening replication. Meiotic preparations consequently expose pairing relationships, chiasmata, and segregation configurations that mitotic metaphase preparations do not, linking observable chromosome behavior to recombination and the reduction from diploid to haploid complements. (ncbi.nlm.nih.gov)

Experimental Foundations and Historical Development

The chromosome theory of inheritance connected microscopic observations of chromosomes with the hereditary factors described by Gregor Mendel. In 1902, Walter Sutton reported observations of grasshopper chromosomes; his 1903 paper, The Chromosomes in Heredity, explicitly related their behavior to Mendelian inheritance. Maternal and paternal chromosomes formed pairs, and their separation during meiosis supplied a physical explanation for the segregation of hereditary factors. Theodor Boveri’s experiments provided complementary evidence: sea-urchin eggs fertilized by more than one sperm underwent abnormal divisions that distributed chromosomes unevenly, and normal development depended on receiving a complete chromosome complement. These observations supported chromosome individuality and differences in hereditary function, rather than treating chromosomes as interchangeable quantities of nuclear material. The resulting theory linked cytology to genetics before the molecular nature of genes was established. (genome.gov)

Harriet Creighton and Barbara McClintock supplied direct evidence connecting genetic recombination with physical chromosome exchange in their 1931 study of maize. They used a distinguishable pair of chromosome 9 homologues: one carried a conspicuous knob at one end and an attached segment derived from chromosome 8 at the other. These visible markers allowed chromosome segments to be followed independently of inherited kernel traits. Crosses also tracked alleles affecting aleurone pigmentation, designated $C/c$, and waxy endosperm, $Wx/wx$. Offspring with recombinant combinations of these genetic markers showed the corresponding exchange of cytological markers. Thus, recombination inferred from breeding results was correlated with an observable exchange between homologous chromosomes, providing experimental support for crossing-over rather than merely assuming a physical exchange from genetic ratios. (pmc.ncbi.nlm.nih.gov)

McClintock’s subsequent chromosome-breakage experiments showed how cytological observations could explain changing phenotypes within a developing organism. Her work in the 1930s and early 1940s established the breakage–fusion–bridge cycle: after a chromosome breaks, the unprotected ends of replicated sister chromatids can fuse, producing a structure with two centromeres. Movement toward opposite poles stretches this structure into an anaphase bridge, which breaks and leaves new ends capable of fusion in another division. Unequal breakage redistributes chromosome material among daughter cells, generating losses and duplications. She related such events to sectors of altered tissue in maize, using their distribution to reconstruct the consequences of earlier cell divisions. The evidence combined chromosome images, breeding experiments, and developmental patterns rather than relying on any one type of observation. (nobelprize.org)

Investigations of unstable maize traits then led McClintock to mobile genetic elements. She identified Dissociation ($Ds$) through chromosome breakage at a particular site on chromosome 9 and found that its activity depended on another factor, Activator ($Ac$). Changes in the genetic location of these factors demonstrated that hereditary elements need not remain at fixed chromosome positions. Insertion into a pigment-associated locus could disrupt its function; subsequent departure during development could restore pigmentation in a cell and its descendants, producing a colored sector. Her 1950 paper, The Origin and Behavior of Mutable Loci in Maize, presented evidence for these mobile controlling elements. This reasoning extended cytogenetics from tracking whole chromosomes and exchanged segments to inferring the movement of elements too small to resolve directly by conventional microscopy. (digirepo.nlm.nih.gov)

Human cytogenetics advanced when preparation methods made chromosomes reliably countable. In 1956, Joe Hin Tjio and Albert Levan established the typical human diploid number as 46, replacing the widely accepted count of 48. They examined cultured embryonic lung fibroblasts, using colchicine to accumulate mitotic cells, hypotonic treatment to separate chromosomes, and controlled squashing to spread them for observation. (sfmg.se) Reports in 1959 connected Down syndrome with an extra chromosome, subsequently identified as chromosome 21, and described the XXY and single-X complements associated with Klinefelter and Turner syndromes. Peripheral-blood lymphocyte culture and improved air-dried preparations subsequently broadened laboratory access. (genome.gov) Chromosome identification improved further with banding: Torbjörn Caspersson, Lore Zech, and collaborators reported reproducible quinacrine fluorescence patterns in 1970, and their 1971 work distinguished all 24 human chromosome types. Band patterns supplied identifiers beyond size and centromere position, allowing rearranged chromosome segments to be recognized more precisely. (sciencedirect.com)

Numerical and Structural Chromosome Variation

Numerical variation affects either individual chromosomes or complete chromosome sets. Aneuploidy is the gain or loss of individual chromosomes relative to the usual complement: in a diploid organism, monosomy leaves one copy of a particular chromosome, $2n-1$, whereas trisomy produces three copies, $2n+1$. Human examples include monosomy X, with 45 chromosomes, and full trisomy 21, with 47. Polyploidy, by contrast, increases the number of complete sets. Triploidy is $3n$, corresponding to 69 human chromosomes, and tetraploidy is $4n$, corresponding to 92. These categories describe chromosome content rather than simply an unusual total count: a structural fusion can reduce chromosome number without removing an entire chromosome’s genetic contribution. (medlineplus.gov)

Structural variation changes the amount, order, orientation, or chromosomal location of genetic material. A deletion removes a segment, either terminally or internally; a duplication supplies an additional copy of a segment. An inversion reverses a segment’s orientation within its chromosome. A paracentric inversion lies within one arm and excludes the centromere, whereas a pericentric inversion includes the centromere and therefore involves both arms. A reciprocal translocation exchanges segments between nonhomologous chromosomes. A Robertsonian translocation joins the long arms of two acrocentric chromosomes, usually with loss of their short arms; in humans, the participating chromosomes are 13, 14, 15, 21, and 22. A balanced carrier of a 13;14 fusion typically has 45 chromosomes, while retaining two copies of each participating long arm. (medlineplus.gov)

Other rearrangements produce distinctive chromosome shapes and dosage patterns. A ring chromosome commonly forms when breaks near both chromosome ends are followed by fusion of the remaining ends; terminal material may be lost, although rings can also form without detectable loss. An isochromosome has two copies of the same arm—two p arms or two q arms—instead of one of each. It therefore combines duplication of one arm with loss of the other. These are structural changes even when the cell’s total chromosome count remains unchanged. (medlineplus.gov)

A rearrangement is balanced when no net gain or loss of genetic material is detected, and unbalanced when material is missing or additional. Balance does not necessarily preserve biological function: a breakpoint can interrupt a gene, create a fusion gene, or alter the relationship between a gene and its regulatory sequences. Moreover, “apparently balanced” describes the resolution of the observation, not proof of nucleotide-level completeness. In a 2017 study, Claire Redin and colleagues examined 273 individuals with congenital anomalies and balanced cytogenetic findings. Sequencing revealed cryptic complexity in 21% of rearrangements; breakpoints in eight individuals altered a regulatory domain containing MEF2C and were associated with reduced expression of that gene. These findings concern a selected clinical cohort, not all balanced-rearrangement carriers. (ncbi.nlm.nih.gov)

Numerical changes can arise through nondisjunction, the failure of homologous chromosomes or sister chromatids to separate during meiosis or mitosis. Chromosome loss can also follow segregation errors, including lagging during anaphase. Structural changes arise through chromosome breakage and incorrect rejoining during DNA repair; end-joining pathways can connect fragments in new arrangements. Classification by origin is separate from classification by structure. An inherited finding is transmitted from a parent; a de novo finding arises newly in the individual. A constitutional finding originates in a gamete or early development and may be widespread or mosaic, whereas an acquired finding develops in a somatic cell lineage, as in a tumor. Mosaicism denotes genetically different cell populations derived from one fertilized egg—for example, populations with two and three copies of chromosome 21 following an early postzygotic division error. (genome.gov)

Conventional Chromosome Preparation and Karyotyping

Conventional chromosome analysis requires viable cells capable of entering mitosis. Specimens therefore include anticoagulated peripheral blood, bone marrow, amniotic fluid, chorionic villi, and tissue samples rather than extracted DNA alone. Preparation depends on the tissue: circulating lymphocytes generally require stimulation, whereas specimens containing actively dividing cells may permit direct preparations or short-term culture. In a common peripheral-blood procedure, phytohemagglutinin stimulates predominantly T lymphocytes, which are cultured for approximately 72 hours before harvesting. Cultured fibroblasts and amniotic-fluid cells require different growth conditions and schedules. (acmg.net)

Before harvest, colchicine or colcemid inhibits microtubule assembly, preventing normal spindle function and accumulating cells with condensed chromosomes. Hypotonic treatment—commonly with 0.075 M potassium chloride—swells the cells and facilitates chromosome separation. Repeated fixation with methanol and acetic acid, often in a 3:1 volume ratio, preserves chromosome morphology and removes much of the surrounding cellular material. The fixed suspension is dropped onto glass slides and dried to produce chromosome spreads. Humidity, temperature, drying rate, and cell concentration affect spreading: overlapping chromosomes obscure bands, while excessive dispersion can make a complete chromosome complement difficult to reconstruct. These variables are adjusted to the specimen rather than governed by a single universal protocol. (pmc.ncbi.nlm.nih.gov)

G-banding usually involves controlled trypsin digestion followed by Giemsa staining, producing reproducible transverse dark and light bands. Dark G-bands tend to represent relatively AT-rich, gene-poor, late-replicating regions; light bands are generally more GC-rich, gene-rich, and early-replicating. These are regional associations, not direct measurements of individual genes or nucleotide sequences. Band order and relative width provide a recognizable pattern for each chromosome, allowing chromosomes of similar size to be distinguished and displaced, missing, or repeated segments to be recognized. Unlike uniform staining, which mainly reveals chromosome number and gross morphology, banding permits comparison of internal chromosome organization. (pmc.ncbi.nlm.nih.gov)

Other staining methods emphasize different features. Q-banding uses fluorescent quinacrine and produces a characteristic pattern broadly corresponding to G-bands. R-banding reverses the dark–light relationship; methods include heat pretreatment followed by Giemsa staining. C-banding preferentially reveals constitutive heterochromatin, especially centromeric regions and the heterochromatic portion of human Yq. Silver nucleolar-organizer-region staining, or AgNOR staining, detects NOR-associated proteins rather than staining ribosomal DNA directly. In humans, these regions occur on the short arms of chromosomes 13, 14, 15, 21, and 22. C-banding and AgNOR staining can consequently clarify centromeric variants, satellite-bearing chromosome material, and some otherwise ambiguous structural findings. (mayo.edu)

A karyotype is the chromosome complement described by number and morphology; the word is also commonly used for its arranged laboratory image. More specifically, a karyogram is an ordered display of chromosome images from one cell, whereas an ideogram is a schematic representation of chromosome shape and band organization. Identification combines relative length, centromere position, and banding pattern. In a human karyogram, homologous autosomes are normally placed together in numbered order, with sex chromosomes displayed separately. The arrangement reorganizes an image for comparison; it does not represent the chromosomes’ original spatial positions within the cell. (genome.gov)

Resolution depends substantially on chromosome condensation. Conventional metaphase chromosomes show fewer, broader bands than the longer chromosomes obtainable at prometaphase or prophase, where those bands resolve into sub-bands. Human band levels are expressed per haploid set: approximately 400 bands may be distinguished at metaphase and 850 at prometaphase. ACMG standards identify the 550-band stage as a goal for peripheral-blood studies. Higher-resolution analysis can reveal smaller structural changes, but chromosome length alone is insufficient: crisp staining, minimal overlap, and reproducible band recognition are essential. An indistinct or poorly spread preparation may conceal changes despite apparently long chromosomes, and band counts do not constitute a uniform base-pair detection threshold across the genome. (pmc.ncbi.nlm.nih.gov)

Fluorescence In Situ Hybridization and Chromosome Painting

Fluorescence in situ hybridization (FISH) localizes selected DNA sequences through complementary base pairing between a labeled probe and its target. Cells, chromosome spreads, or tissue sections are fixed on glass slides; target DNA and probe DNA are denatured into single strands and then allowed to hybridize. Probes carry fluorescent dyes directly or chemical labels subsequently detected by fluorescent reagents. Post-hybridization washes remove unbound and insufficiently matched probe, while a DNA counterstain, commonly DAPI, outlines chromosomes or nuclei. A fluorescence microscope with appropriate excitation and emission filters reveals the signals. Because hybridization occurs within the preparation rather than in extracted DNA, each signal remains associated with an identifiable chromosome, nucleus, or tissue region, although fixation and spreading can alter native spatial organization. (pmc.ncbi.nlm.nih.gov)

Probe design determines the biological question. Locus-specific probes recognize a defined genomic region and can establish its chromosome location or assess deletion, duplication, and amplification. For example, a published protocol illustrates a red MYC probe alongside a green chromosome-8 centromeric control, allowing locus signals to be compared with a chromosome reference. Centromeric probes, usually targeting alpha-satellite repeats near the centromere, are used for chromosome enumeration and can complement locus-specific probes when distinguishing regional loss from whole-chromosome loss. Subtelomeric probes recognize chromosome-end-specific sequences adjacent to telomeres, rather than the telomeric repeat shared among chromosome ends; their absence or relocation can reveal terminal deletions or cryptic exchanges. Whole-chromosome paints are mixtures of probes distributed along a chromosome. They identify the chromosome of origin of substantial segments, for example when a derivative chromosome contains material from two different chromosomes. (pmc.ncbi.nlm.nih.gov)

Metaphase FISH places signals on individually distinguishable condensed chromosomes, making it possible to determine whether a target remains on its original chromosome or has moved to another. Interphase FISH examines nuclei without requiring cells to enter mitosis, permitting targeted analysis of nondividing cells and tissue sections. For a single-copy autosomal target in an intact, unreplicated diploid nucleus, two signals are normally expected; reproducible departures from that pattern can indicate altered copy number. Interphase analysis does not itself provide a complete chromosome image, however. Signal overlap, DNA replication, incomplete hybridization, and truncation of nuclei in tissue sections complicate simple counting, so signals must be interpreted using assay-specific scoring criteria and controls. (pmc.ncbi.nlm.nih.gov)

Multicolor chromosome painting extends this approach across the chromosome complement. In April 1996, Michael R. Speicher, Stephen Gwyn Ballard, and David C. Ward reported multiplex FISH, or M-FISH, using combinatorially labeled paints, fluorescence filters, and computer classification. In July 1996, Evelin Schröck and colleagues described spectral karyotyping (SKY), which identifies chromosome-specific combinations through their emission spectra. Standard human implementations distinguish 24 chromosome classes—the 22 autosomes, X, and Y—not 46 individually unique colors. M-FISH records separate fluorescence channels, whereas SKY measures spectral signatures; both use image processing to assign display colors. A chromosome containing differently classified segments can thereby reveal interchromosomal exchanges that are difficult to reconstruct from banding alone, including complex rearrangements and the origins of unidentified marker chromosomes. (pubmed.ncbi.nlm.nih.gov)

The apparent breadth of a colored chromosome image does not eliminate probe-dependent limitations. A locus-specific assay interrogates only the selected region: a deletion outside its target can remain undetected. Subtelomeric panels examine chromosome ends but do not survey every internal locus. Whole-chromosome paints principally distinguish chromosome origins; an inversion confined to one chromosome generally retains the same paint identity, and small exchanged segments may escape classification. Multicolor analysis can also misclassify boundaries where overlapping chromosomes or fluorescence spreading distort the measured signature. Consequently, chromosome painting identifies the contributing chromosomes of a rearrangement more readily than its precise breakpoints or affected genes; finer localization requires additional regional or locus-specific probes. (genome.gov)

Cytogenomic Arrays and Genome-Wide Copy-Number Analysis

Comparative genomic hybridization (CGH) measures the relative abundance of DNA sequences across the genome. In the chromosome-based method reported by Anne Kallioniemi and colleagues in 1992, test DNA and normal reference DNA are labeled with different fluorochromes and hybridized together to normal metaphase chromosome spreads. Their fluorescence-intensity ratio along each chromosome reveals relative gains and losses in the test specimen; the chromosomes serve as a mapping substrate rather than as images of the specimen’s own chromosomes. Array CGH replaces these spreads with immobilized DNA probes of known genomic location. Matrix-based CGH was reported by Silvia Solinas-Toldo and colleagues in 1997, followed by Daniel Pinkel and colleagues’ high-resolution microarray study in 1998. This transition made resolution depend principally on probe coverage and signal quality rather than on the optical separation of chromosome regions. (pubmed.ncbi.nlm.nih.gov)

In chromosomal microarray analysis (CMA), DNA extracted from a specimen is hybridized to an array, scanned, and analyzed for contiguous regions with abnormal signal intensity. Array CGH uses directly competing test and reference signals, whereas SNP-array copy-number analysis commonly compares specimen intensity with a computational reference dataset. With a diploid reference, normalized test-to-reference ratios below or above one indicate losses or gains, respectively. Algorithms combine neighboring probes into segments instead of treating each intensity fluctuation as an independent abnormality. Arrays can consequently detect submicroscopic deletions and duplications that are not recognizable by conventional chromosome banding. However, “genome-wide” describes distributed coverage, not measurement of every nucleotide: poorly represented regions remain less accessible. (gimjournal.org)

SNP arrays add allele information by distinguishing alternative bases at polymorphic sites. Two complementary plots are commonly examined: log R ratio, which measures normalized total intensity, and B-allele frequency, which represents the relative contribution of the allele designated B. In a typical diploid region, AA, AB, and BB genotypes cluster near B-allele frequencies of $0$, $0.5$, and $1$. A three-copy region can produce additional clusters near $1/3$ and $2/3$, corresponding to AAB and ABB. Conversely, an extended region containing only AA and BB calls, without reduced total intensity, indicates copy-neutral homozygosity rather than a deletion. Such regions can reflect shared ancestral inheritance or uniparental isodisomy; their distribution supplies evidence about the underlying mechanism, but homozygosity alone does not establish parental origin. (illumina.com)

Probe spacing is not equivalent to validated analytical resolution. Reliable detection also depends on how many consecutive probes support a change, their hybridization performance, background noise, and the algorithm’s thresholds. Breakpoints are therefore bounded by the last apparently normal and first abnormal probes, rather than necessarily localized to an exact nucleotide. Nor does higher resolution make every detected copy-number variant biologically consequential. A small deletion affecting a dosage-sensitive gene may be important, while a larger change may overlap tolerated variation. The ACMG–ClinGen interpretation framework published in 2020 evaluates genomic content, dosage sensitivity, population evidence, inheritance, and reported cases; physical size alone is not a classification rule. (acmg.net)

Copy-number analysis generally misses balanced translocations and inversions because these rearrange DNA without changing its abundance. It also cannot ordinarily establish where an additional segment is inserted or whether separate abnormalities occupy the same cell. Extracted DNA pools signals from the sampled cells, losing the direct cellular localization retained by microscopy. For mosaicism, an abnormal population’s signal is diluted by other cells; detectability varies with its proportion, the size and copy-number state of the alteration, genomic location, DNA quality, and assay performance. SNP allele patterns can provide additional evidence, but there is no universal mosaicism threshold applicable to every region and platform. A negative array result therefore neither excludes all chromosome rearrangements nor rules out low-level or tissue-restricted mosaicism. (acmg.net)

Constitutional and Reproductive Cytogenetics

Constitutional cytogenetics investigates chromosome complements associated with an individual’s development, rather than changes restricted to a tumor. Its established clinical applications include investigating congenital anomalies, developmental delay, intellectual disability, infertility, and recurrent pregnancy loss. These applications address different questions: whether chromosome imbalance contributes to developmental findings, whether sex-chromosome variation affects reproductive function, or whether a parental rearrangement can produce chromosomally unbalanced conceptions. Conventional chromosome analysis identifies whole-chromosome changes and many large structural rearrangements; cytogenomic arrays extend investigation to submicroscopic deletions and duplications but generally do not detect balanced rearrangements. The ACMG’s 2013 microarray standards documented applications in intellectual disability, autism, and multiple congenital anomalies; reproductive investigations also include chromosome analysis of parents and pregnancy-loss tissue. (acmg.net)

Three findings illustrate distinct relationships between chromosome constitution and recognized conditions. In Down syndrome, trisomy 21 usually produces 47 chromosomes, with three separate copies of chromosome 21; other cases involve additional chromosome-21 material in a translocation or an extra chromosome in only some cells. Monosomy X, conventionally designated 45,X, accounts for about half of individuals with Turner syndrome; others have structural changes of the X chromosome or mosaicism. Associated findings include short stature and reduced ovarian function, but their occurrence and severity vary. 22q11.2 deletion syndrome illustrates a segmental imbalance: most affected individuals lack approximately three million base pairs from one chromosome 22. Its manifestations can include congenital heart abnormalities, palatal differences, immune dysfunction, and developmental difficulties, with substantial variation even within families. None of these chromosome findings provides a complete description of an individual’s abilities, health, or phenotype. (medlineplus.gov)

Parental structural rearrangements connect chromosome architecture with reproductive outcomes. A balanced reciprocal translocation carrier may have no evident effects from the rearrangement, yet during meiosis the two rearranged chromosomes and their normal homologues can pair as a four-chromosome configuration, or quadrivalent. Alternate segregation sends the two normal chromosomes to one pole and the two derivative chromosomes to the other, producing normal or balanced gametes. Adjacent segregation instead produces gametes with duplicated and missing chromosome segments; after fertilization, these can generate partial trisomy and partial monosomy. Such imbalances may cause pregnancy loss or congenital and developmental conditions. Robertsonian translocations involving chromosome 21 provide another example: an unaffected balanced carrier can transmit a complement containing excess chromosome-21 material, resulting in translocation Down syndrome. Reproductive outcomes depend on the particular chromosomes, breakpoints, and segregation products, rather than following a single probability applicable to all carriers. (pmc.ncbi.nlm.nih.gov)

Prenatal cytogenetic analysis examines specimens obtained by chorionic-villus sampling or amniocentesis. Chorionic-villus sampling, usually performed at 10–13 weeks of gestation, obtains placental tissue; amniocentesis, usually performed at 15–20 weeks, obtains amniotic fluid containing fetal-derived cells. Depending on the laboratory question, these specimens support chromosome analysis, targeted fluorescence in situ hybridization, or cytogenomic arrays. These are diagnostic analyses of sampled cells or DNA, although each has defined limits of detection. Cell-free-DNA screening instead analyzes circulating DNA fragments in maternal plasma, with the pregnancy-derived component originating predominantly from the placenta. It estimates the likelihood of selected chromosome conditions and is not itself a diagnostic fetal chromosome result. (acog.org)

Confined placental mosaicism complicates this distinction because an abnormal chromosome lineage may be present in the placenta but absent from the fetus. Chorionic-villus direct preparations principally examine cytotrophoblast cells, whereas cultured villus preparations examine mesenchymal-core cells; these placental compartments can have different chromosome complements. Placental mosaicism can therefore produce a positive cell-free-DNA screen without the corresponding fetal abnormality, or a mosaic chorionic-villus result whose fetal significance remains uncertain. Amniotic-fluid analysis samples a different cellular source and can help distinguish placental restriction from fetal involvement, while remaining subject to sampling and mosaicism-detection limits. (pmc.ncbi.nlm.nih.gov)

Acquired Chromosome Changes in Cancer

Acquired chromosome abnormalities arise in somatic cells and characterize an abnormal cell population, rather than necessarily belonging to an individual’s constitutional chromosome complement. Tumor specimens can also contain constitutional variants; comparison with unaffected tissue may help establish their origin. A cytogenetic clone is a population inferred to descend from one progenitor cell through shared chromosome abnormalities. In conventional chromosome analysis, the standard criteria are at least two cells with the same structural abnormality or chromosome gain, or at least three cells missing the same chromosome. Related populations sharing an initial abnormality but carrying additional changes can reveal clonal evolution. (acmg.net)

The Philadelphia chromosome provides a direct connection between a visible chromosome rearrangement and a cancer-driving molecular mechanism. Peter Nowell and David Hungerford described the unusually small chromosome in 1960 in cells from patients with chronic myeloid leukemia (CML). The characteristic reciprocal translocation, t(9;22)(q34;q11.2), brings together ABL1 from chromosome 9 and BCR from chromosome 22; the resulting BCR::ABL1 fusion lies on the derivative chromosome 22 called the Philadelphia chromosome. Its protein has constitutively active tyrosine-kinase activity, promoting proliferation and inhibiting apoptosis without the normal activating signals. This acquired alteration is not inherited. In approximately 5–10% of CML cases, variant Philadelphia translocations involve additional chromosomes. Philadelphia-positive acute leukemias also occur, so the finding is interpreted alongside the cellular and clinical features rather than identifying CML by itself. (cancer.gov)

Rearrangements can instead produce proteins that alter gene expression. In Ewing sarcoma, t(11;22)(q24;q12) joins EWSR1 on chromosome 22 to FLI1 on chromosome 11. The EWSR1::FLI1 fusion occurs in approximately 85–90% of pediatric cases and encodes an abnormal transcription factor that regulates genes involved in tumor growth, contrasting with the kinase mechanism of BCR::ABL1. Other fusion partners occur, and an EWSR1 rearrangement alone is not specific for Ewing sarcoma: break-apart fluorescence in situ hybridization (FISH) demonstrates disruption of the locus but does not identify its partner. Fusion characterization therefore contributes to distinguishing Ewing sarcoma from other round-cell tumors. (cancer.gov)

Chromosome gains, losses, and regional amplification change the amount of genetic material rather than necessarily creating a fusion. Deletions can remove tumor-suppressor genes, whereas amplification supplies many additional copies of a locus. For example, MYCN amplification occurs in about 25% of neuroblastomas; amplified tumors typically carry approximately 50–100 copies, although the number varies widely, and amplification is associated with aggressive disease. Additional abnormalities can also accumulate within an established clone: in CML, changes associated with progression include trisomy 8, an isochromosome involving chromosome 17, and an additional Philadelphia chromosome. These findings distinguish the founding rearrangement from later changes accompanying disease evolution. (medlineplus.gov)

Cancer cytogenetic findings have established roles in tumor classification, prognostic assessment, and identifying genetically defined groups with targeted treatments. Serial studies can document persistence or recurrence of an abnormal population and detect additional clonal changes. In CML, chromosome analysis and FISH assess Philadelphia-positive cells, while molecular BCR::ABL1 assays provide complementary monitoring of the fusion. Interpretation combines chromosome findings with pathology and molecular results; neither a rearrangement nor its disappearance from a limited sample supplies a complete assessment of disease. (acmg.net)

Specimen composition constrains these applications. Hematological studies commonly use bone marrow aspirates collected with sodium heparin; peripheral blood is informative when circulating neoplastic cells are present. Conventional solid-tumor chromosome analysis requires viable cells from fresh tissue, whereas validated FISH and microarray assays can use formalin-fixed, paraffin-embedded material. Histological review helps identify tumor-rich areas. Normal cells, stroma, and necrotic tissue can dilute or compromise the abnormal population, and culture can favor particular cell populations. Consequently, the proportion of abnormal metaphases need not equal the tumor proportion in the original specimen, and a negative result depends on tumor representation and the assay’s detection limits. (acmg.net)

Plant, Animal, and Evolutionary Cytogenetics

In maize, visible chromosome landmarks allow inherited traits to be followed alongside the physical structures carrying them. The 1931 experiments of Harriet Creighton and Barbara McClintock, introduced in the historical section, used chromosome 9 homologues distinguished by a dark-staining terminal knob and an attached segment of chromosome 8 resulting from a reciprocal translocation. These landmarks bracketed a region containing genetic markers, including C, associated with aleurone pigmentation, and Wx, associated with starch composition. Comparing offspring phenotypes with their chromosome configurations connected crossing-over between genetic markers to the exchange of recognizable chromosome segments. The essential experimental advantage was that chromosome identity and inheritance could be assessed independently, rather than inferring physical exchange solely from trait combinations. (pmc.ncbi.nlm.nih.gov)

Maize also made genome instability observable through changes in chromosome structure and patterned phenotypes. In McClintock’s investigations, broken chromosome ends could fuse, produce a bridge when their centromeres moved toward opposite poles, and break again, initiating repeated breakage–fusion–bridge cycles. Her subsequent work on mutable loci, reported in 1950, connected chromosome breakage and changes in gene activity with the controlling elements Activator (Ac) and Dissociation (Ds). In appropriate chromosome configurations, Ds-associated breakage depended on Ac and could remove chromosome material carrying visible markers; changes occurring during development produced sectors with different pigmentation. These observations linked cytological abnormalities, the developmental timing of an event, and the behavior of transposable elements, rather than treating a variegated kernel as a single, uniform mutant. (nobelprize.org)

Comparative chromosome painting identifies corresponding chromosome-scale regions across species by hybridizing chromosome-derived probes from one species to another’s chromosome spreads. Reciprocal painting helps delimit these correspondences in both directions. Conserved synteny—the retention of homologous genomic regions on the same chromosome—provides evidence for reconstructing fusions, fissions, and other rearrangements, although painting alone does not establish detailed gene order within a painted block. In 2003, Fengtang Yang and colleagues compared human chromosomes with those of the aardvark, whose diploid number is $2n=20$, and African and Asian elephants, both with $2n=56$. Their maps, interpreted alongside other placental-mammal comparisons, supported a proposed ancestral complement of $2n=44$, including conserved associations of regions located on separate human chromosomes. The ancestral complement was an evolutionary inference, not a directly observed karyotype; distinguishing ancestral associations from lineage-specific rearrangements required comparison across multiple branches of the mammalian tree. (pmc.ncbi.nlm.nih.gov)

Birds and many reptiles possess conspicuous macrochromosomes alongside much smaller microchromosomes. These small chromosomes are not merely chromosome fragments: they commonly have high gene density, high GC content, and relatively few transposable elements. A 2021 study by Paul D. Waters and colleagues combined cytological observations, genome-sequence comparisons, and chromosome-conformation data to investigate their evolutionary history. Microchromosomes were extensively conserved among birds, while turtles and squamates retained different subsets following lineage-specific fusions with other microchromosomes or macrochromosomes. Correspondence with small chromosomes in amphioxus supported an ancient origin for many of these genomic blocks. Their tendency to associate in a central nuclear compartment further connected chromosome size classes with three-dimensional genome organization. Consequently, a reduction in microchromosome number need not imply loss of the corresponding genes: their sequences may instead have become incorporated into larger chromosomes. (pmc.ncbi.nlm.nih.gov)

The platypus illustrates a different departure from familiar human chromosome organization. Chromosome-painting studies reported in 2004 resolved five distinct X chromosomes and five distinct Y chromosomes in males; females carry two copies of each X chromosome. During male meiosis, the ten sex chromosomes form an alternating multivalent chain, with neighboring elements connected through homologous pairing regions. Alternate segregation produces sperm carrying either the five X chromosomes or the five Y chromosomes, rather than a single X or Y. The labels X and Y therefore describe sex-associated inheritance in this system, not five interchangeable copies of the human sex chromosomes. Resolving the chain required identifying its individual elements and following their meiotic behavior, demonstrating why neither a single sex-chromosome pair nor the human chromosome complement can serve as a universal animal model. (doi.org)

Nomenclature, Interpretation, and Laboratory Quality

The International System for Human Cytogenomic Nomenclature (ISCN) standardizes the description of chromosome findings across laboratories; its 2024 edition was edited by Ros Hastings, Sarah Moore, and Nicole Chia. In 47,XX,+21, the first number records the total chromosome count, XX identifies the sex-chromosome complement, and +21 denotes an additional chromosome 21. The rearrangement description t(9;22)(q34;q11.2) identifies a translocation involving chromosomes 9 and 22, with cytologically assigned breakpoints at 9q34 and 22q11.2. Such notation describes an observation, not by itself a molecularly established gene fusion or its clinical consequences. (karger.com)

Chromosome addresses distinguish the short arm, p, from the long arm, q, and number regions and bands outward from the centromere. Thus, 22q11.2 means chromosome 22, long arm, region 1, band 1, sub-band 2; it is not a decimal measurement of distance. These addresses refer to staining patterns visible at particular levels of chromosome resolution. Sequence coordinates instead specify positions in DNA and require an identified reference-genome assembly, such as GRCh37 or GRCh38. A breakpoint assigned to a band does not establish its exact nucleotide position, while array-defined interval boundaries depend on probe coverage and analytical resolution. Reports therefore distinguish observed cytogenetic locations from sequence-based coordinates and state the reference assembly when applicable. (medlineplus.gov)

Interpretation combines chromosome structure, interval size, gene content, dosage sensitivity, inheritance, population frequency, published cases, and the individual’s clinical findings. The 2020 ACMG–ClinGen recommendations, led by Erin Rooney Riggs and colleagues, established an evidence-scoring framework for constitutional copy-number variants with five categories: pathogenic, likely pathogenic, uncertain significance, likely benign, and benign. Their explicit distinction between variant classification and an individual’s diagnosis prevents an abnormal laboratory result from automatically becoming an explanation of every observed phenotype. A deletion may have well-established pathogenicity yet explain only part of a person’s presentation. Conversely, inheritance from an apparently unaffected parent is relevant evidence but does not automatically establish benignity, because penetrance and expression can vary. These constitutional categories are not interchangeable with classification frameworks for acquired tumor abnormalities. (pmc.ncbi.nlm.nih.gov)

Laboratory validation establishes accuracy, precision, analytical sensitivity and specificity, reportable ranges, and specimen-specific performance before clinical implementation. Routine controls address specimen identity, preparation quality, hybridization performance, and analytical thresholds; external proficiency testing assesses performance beyond an individual laboratory. Cell numbers also require explicit documentation. The 2019 European constitutional cytogenomic guidelines distinguish complete band-by-band analysis from counting chromosomes or scoring a specified feature: for mosaicism exclusion or investigation of a single-cell anomaly, their minimum is two fully analyzed metaphases plus 28 additional counted cells. This is a defined analytical minimum, not proof that all low-level mosaicism has been excluded. Independent confirmation with another method is used where validation requirements or ambiguous findings require it, rather than assumed necessary for every result. A negative report applies only to the specimen, variant classes, resolution, and detection thresholds actually examined. (acmg.net)

Sampling and culture affect representativeness and reproducibility. Preferential growth can change the proportions of cell populations, and culture-associated chromosome changes may produce apparent abnormalities absent from the original tissue. Comparison across independent cultures helps distinguish such artifacts from reproducible findings. Maternal-cell contamination can introduce a second genotype into prenatal material; tissue-specific mosaicism means that blood, skin, placenta, and other tissues need not contain identical proportions of abnormal cells. Consequently, the percentage observed in a culture is not necessarily the percentage throughout the individual. (nature.com)

Clinical practice also requires informed consent and protection of confidential genetic information. Pre-test communication addresses assay scope, limitations, and the possibility of uncertain or incidental findings. Reports and subsequent explanations distinguish uncertainty from demonstrated disease causation and identify findings unrelated to the original referral question. Access to genetic results is governed by applicable confidentiality requirements; in the United States, genetic information held in medical records is generally covered by the HIPAA Privacy Rule. (nature.com)

Integration with Sequencing and Optical Genome Mapping

Chromosome microscopy and DNA sequencing provide different kinds of evidence about the same rearrangement. Karyotyping establishes chromosome number and large-scale architecture in individual metaphase cells; fluorescence in situ hybridization (FISH) localizes selected sequences within chromosomes or interphase nuclei. Sequencing can identify the nucleotide junctions connecting rearranged segments, revealing disrupted genes, small insertions or deletions, and breakpoint features that microscopy cannot resolve. Short reads can detect structural variants, but repetitive sequences may prevent their unique alignment; long reads can span repeats and junctions that remain ambiguous in short-read data. Conversely, routine sequencing of extracted DNA does not preserve the original arrangement of chromosomes within individual cells. Thus, greater sequence resolution does not reproduce all the cellular information supplied by cytogenetic observation. (genome.gov)

Optical genome mapping (OGM) examines the spacing and order of fluorescent labels along long, extracted DNA molecules rather than reading every nucleotide. In a widely studied implementation, sequence-specific labeling produces molecular patterns; molecules are linearized in nanochannels, imaged, and computationally assembled or aligned against a reference map. Changes in label spacing, order, or chromosome assignment support identification of deletions, insertions, inversions, and translocations, while molecular coverage provides copy-number information. The 2024 study Full characterization of unresolved structural variation through long-read sequencing and optical genome mapping described OGM molecules beginning at approximately 150 kilobases, compared with typical long sequencing reads of 10–100 kilobases. An optical map is therefore neither an image of an intact chromosome nor a base-by-base sequence: its breakpoint resolution depends on informative labels and map alignment, and it does not directly identify single-nucleotide substitutions. (pmc.ncbi.nlm.nih.gov)

Integration can distinguish a simple cytogenetic description from a more complicated molecular structure. In that 2024 study, six individuals with unresolved structural variants underwent long-read sequencing, and three additionally underwent OGM. One apparently balanced t(2;21) proved to involve chromosomes 2, 5, and 21, with 23 breakpoints distributed across approximately 1.4 megabases. Reconstruction identified a 25-kilobase deletion affecting ZEB2 exons 5–10. OGM supported the reconstructed arrangement and detected that deletion, but missed some smaller fragments; eight junctions identified only through long-read sequencing were subsequently confirmed by polymerase chain reaction. This example separates complementary tasks: broad structural mapping, nucleotide-level junction characterization, and independent verification of difficult findings. (pmc.ncbi.nlm.nih.gov)

Validation must measure performance separately for different variant classes, genomic regions, and specimen types rather than assigning a single universal detection limit. Relevant questions include whether balanced exchanges and copy-number changes are both covered, whether repetitive or centromeric breakpoints are accessible, and how reliably minor abnormal populations are detected in mosaic samples. Bulk molecular measurements do not directly count abnormal cells, so agreement with microscopy must account for sampling and assay sensitivity. A 2024 constitutional validation study testing 87 previously identified structural variants reported 98% concordance, but discordant findings included a translocation with a centromeric breakpoint, a duplication involving pseudoautosomal region 1, and a mosaic triplication associated with a marker chromosome. Such discrepancies identify specific analytical limitations that an overall concordance percentage can obscure. (pmc.ncbi.nlm.nih.gov)

Multisite studies provide evidence for implementation without establishing that every existing assay can be replaced. In 2023, M. Anwar Iqbal and colleagues evaluated 409 samples across five testing sites: 404 yielded interpretable OGM data, technical concordance with previously reported standard-of-care findings was 399/401, and blinded detection and classification agreement was 364/373. These are distinct measures of workflow success, analytical agreement, and interpretive agreement—not interchangeable estimates of diagnostic sensitivity. Adoption therefore depends on the validated specimen workflow, variant spectrum, software, reproducibility, and management of discordant results. Demonstrating concordance in defined cohorts is separate from demonstrating improved diagnostic outcomes across all indications; karyotyping, FISH, arrays, sequencing, and OGM retain different evidentiary roles where their validated capabilities do not overlap. (pmc.ncbi.nlm.nih.gov)

References

1. Cytogeneticsgenome.gov
2. Glossaryncbi.nlm.nih.gov
3. Chromosome Abnormalities Fact Sheetgenome.gov
4. Talking Glossary of Genetic Termsgenome.gov
5. Chromosomes Fact Sheetgenome.gov
6. What is a chromosome?medlineplus.gov
7. An Overview of M Phase — Molecular Biology of the Cellncbi.nlm.nih.gov
8. GeneReviews Glossaryncbi.nlm.nih.gov
9. Mitosis — Molecular Biology of the Cellncbi.nlm.nih.gov
10. Meiosis — Molecular Biology of the Cellncbi.nlm.nih.gov
11. Meiosis and Fertilization — The Cellncbi.nlm.nih.gov
12. 1902: Chromosome Theory of Hereditygenome.gov
13. Boveri’s long experiment: Sea urchin merogones and the establishment of the role of nuclear chromosomes in developmentpmc.ncbi.nlm.nih.gov
14. A Correlation of Cytological and Genetical Crossing-Over in Zea Mayspmc.ncbi.nlm.nih.gov
15. Methods & Logicdosequis.colorado.edu
16. Barbara McClintock — Nobel Lecturenobelprize.org
17. The Origin and Behavior of Mutable Loci in Maizedigirepo.nlm.nih.gov
18. Spatial Configuration of Transposable Element Ac Termini Affects Their Ability to Induce Chromosomal Breakage in Maizepmc.ncbi.nlm.nih.gov
19. The Chromosome Number of Mansfmg.se
20. 1959: Chromosome Abnormalities Identifiedgenome.gov
21. History and evolution of cytogeneticspmc.ncbi.nlm.nih.gov
22. Can changes in the number of chromosomes affect health and development?: MedlinePlus Geneticsmedlineplus.gov
23. Can changes in the structure of chromosomes affect health and development?: MedlinePlus Geneticsmedlineplus.gov
24. Robertsonian Translocations: An Overview of 872 Robertsonian Translocations Identified in a Diagnostic Laboratory in Chinajournals.plos.org
25. Chromosomal Abnormalities - Understanding Geneticsncbi.nlm.nih.gov
26. The genomic landscape of balanced cytogenetic abnormalities associated with human congenital anomaliesbroadinstitute.org
27. About Down Syndromegenome.gov
28. Chromosome elimination in micronuclei: a common cause of hypoploidypmc.ncbi.nlm.nih.gov
29. Non-homologous end joining shapes the genomic rearrangement landscape of chromothripsis from mitotic errorspmc.ncbi.nlm.nih.gov
30. ACMG Standards and Guidelines: Section E, Clinical Cytogeneticsacmg.net
31. Micronuclei with multiple copies of the X chromosome: do chromosomes replicate in micronuclei?pmc.ncbi.nlm.nih.gov
32. Chromosome Preparation From Cultured Cellspmc.ncbi.nlm.nih.gov
33. Genome Data Viewer Helpncbi.nlm.nih.gov
34. Routine cytogenetic analysis — Cytogenetics Core — Mayo Clinic Researchmayo.edu
35. G, R and C banding patterns of human chromosomes produced by heat treatment in organic and inorganic salt solutionspubmed.ncbi.nlm.nih.gov
36. Comparative morphometric study of AgNORs in variants of ameloblastomapmc.ncbi.nlm.nih.gov
37. Karyotypegenome.gov
38. Chromosome Architecture and Genome Organizationpmc.ncbi.nlm.nih.gov
39. Fluorescence In Situ Hybridization of Cells, Chromosomes, and Formalin-Fixed Paraffin-Embedded Tissuespmc.ncbi.nlm.nih.gov
40. Fluorescence In Situ Hybridization (FISH)genome.gov
41. Fluorescence In Situ Hybridization Fact Sheetgenome.gov
42. Cryptic Translocation Identification in Human and Mouse Using Several Telomeric Multiplex FISH (TM-FISH) Strategiesnature.com
43. One-fits-all pretreatment protocol facilitating Fluorescence In Situ Hybridization on formalin-fixed paraffin-embedded, fresh frozen and cytological slidespmc.ncbi.nlm.nih.gov
44. Karyotyping human chromosomes by combinatorial multi-fluor FISHpubmed.ncbi.nlm.nih.gov
45. Multicolor spectral karyotyping of human chromosomes.pubmed.ncbi.nlm.nih.gov
46. Limitations of Chromosome Classification by Multicolor Karyotypingpmc.ncbi.nlm.nih.gov
47. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors.pubmed.ncbi.nlm.nih.gov
48. Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalancespubmed.ncbi.nlm.nih.gov
49. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarraysnature.com
50. Interpreting Infinium Assay Data for Whole-Genome Structural Variationillumina.com
51. Technical standards for the interpretation and reporting of constitutional copy number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen)pmc.ncbi.nlm.nih.gov
52. Down syndrome: MedlinePlus Geneticsmedlineplus.gov
53. Turner syndrome: MedlinePlus Geneticsmedlineplus.gov
54. 22q11.2 deletion syndrome: MedlinePlus Geneticsmedlineplus.gov
55. Risk Factors Affecting Alternate Segregation in Blastocysts From Preimplantation Genetic Testing Cycles of Autosomal Reciprocal Translocationspmc.ncbi.nlm.nih.gov
56. Interaction of acrocentric chromosome involved in translocation and sex of the carrier influences the proportion of alternate segregation in autosomal reciprocal translocationspubmed.ncbi.nlm.nih.gov
57. Amniocentesisacog.org
58. Society for Maternal-Fetal Medicine Consult Series #74: Cell-free DNA screening for aneuploidies: Updated guidancepmc.ncbi.nlm.nih.gov
59. Society for Maternal-Fetal Medicine: Cell-free DNA visual resourceassets.noviams.com
60. Milestones in Cancer Research and Discoverycancer.gov
61. Chronic myeloid leukemia: MedlinePlus Geneticsmedlineplus.gov
62. Chromosome 22: MedlinePlus Geneticsmedlineplus.gov
63. Ewing Sarcoma Treatment (PDQ®)cancer.gov
64. ETV6 Protein Could Be an Important Target for Ewing Sarcoma Treatmentcancer.gov
65. MYCN gene: MedlinePlus Geneticsmedlineplus.gov
66. Neuroblastoma: MedlinePlus Geneticsmedlineplus.gov
67. BCR-ABL1 Genetic Testmedlineplus.gov
68. Reciprocal chromosome painting among human, aardvark, and elephant (superorder Afrotheria) reveals the likely eutherian ancestral karyotypepmc.ncbi.nlm.nih.gov
69. Microchromosomes are building blocks of bird, reptile, and mammal chromosomespmc.ncbi.nlm.nih.gov
70. PNAS202112494_proof.pdfddd.uab.cat
71. In the platypus a meiotic chain of ten sex chromosomes shares genes with the bird Z and mammal X chromosomespubmed.ncbi.nlm.nih.gov
72. How do geneticists indicate the location of a gene?medlineplus.gov
73. Technical laboratory standards for interpretation and reporting of acquired copy-number abnormalities and copy-neutral loss of heterozygosity in neoplastic disorders: a joint consensus recommendation from the American College of Medical Genetics and Genomics (ACMG) and the Cancer Genomics Consortium (CGC)nature.com
74. European guidelines for constitutional cytogenomic analysisnature.com
75. Genetic Testing Fact Sheetcancer.gov
76. Long-read sequencing and optical mapping generates near T2T assemblies that resolves a centromeric translocationpmc.ncbi.nlm.nih.gov
77. Optical genome mapping enables constitutional chromosomal aberration detectionpmc.ncbi.nlm.nih.gov
78. Full characterization of unresolved structural variation through long-read sequencing and optical genome mappingpmc.ncbi.nlm.nih.gov
79. Optical Genome Mapping as a Potential Routine Clinical Diagnostic Methodpmc.ncbi.nlm.nih.gov
80. Multisite Assessment of Optical Genome Mapping for Analysis of Structural Variants in Constitutional Postnatal Casespmc.ncbi.nlm.nih.gov